Application of Fiberoptic Bronchoscope in the Treatment of Severe Mycoplasma Pneumonia in Children

Abstract

Abstract: Objective To evaluate the efficacy of fiberoptic bronchoscopy in alleviating severe mycoplasma pneumonia in children. Method A total of 50 children with severe mycoplasma pneumonia who were hospitalized in Liaocheng Second People's Hospital from January 2021 to January 2022 were selected as the research objects, and they were randomized divided into two groups. The control group was given azithromycin and methylprednisolone succinate. Sodium and other conventional anti-infective drug regimens were given, and the experimental group was also given a bronchoalveolar lavage regimen with fiberoptic bronchoscopy. The differences in the treatment effect, symptom improvement time, hospital stay, inflammatory indexes and complications were compared between the two groups. Results The total effective rate of children with severe mycoplasma pneumoniae pneumonia in experimental group was higher than that in control group, but the difference was not statistically significant (P>0.05). Temperature recovery time index, rales disappearance time index, cough disappearance time index and hospital stay index in the experimental group were lower than in the control group (P<0.05). The levels of C-reactive protein (CRP), erythrocyte sedimentation rate and procalcitonin (PCT) in the two groups after treatment were lower than those before treatment (P<0.05). The levels of CRP, erythrocyte sedimentation rate and PCT in the experimental group were lower than those in the control group (P<0.05). There was no significant difference in complication rate between the two groups (P>0.05). Conclusion Compared with the conventional anti-infection regimen, fiberoptic bronchoscopy can achieve better results in the treatment of severe mycoplasma pneumonia in children. It can further shorten the hospitalization time, promote the improvement of inflammatory factors in children, and fiberoptic bronchoscopy treatment has no obvious adverse events.

Key words: fiberoptic bronchoscope, children, severe mycoplasma pneumonia, erythrocyte sedimentation rate, procalcitonin

CLC Number:

R563.1

YANG Li-kun. Application of Fiberoptic Bronchoscope in the Treatment of Severe Mycoplasma Pneumonia in Children[J]. ZHONGHUA YANGSHENG BAOJIAN, 2023, 41(5): 11-14.

References

[1] 洪晓纯,王忠,邹姒妮,等.儿童支原体肺炎CT影像学特点及与支气管镜检查对照分析[J].实用放射学杂志,2021,37(12):2047-2050.
[2] 王子威,胡彦宏,何瑜娜,等.纤维支气管镜肺泡灌洗与甲泼尼龙治疗难治性肺炎支原体肺炎的疗效比较[J].北京医学,2021,43(2):126-129.
[3] 周蒙,孟令建,刘琳,等.支原体肺炎行多次支气管镜下灌洗的影响因素分析及预测模型构建[J].徐州医科大学学报,2021,41(8):611-615.
[4] 李伟,曹丽,马统帅,等.支气管镜联合药物治疗对支原体感染大叶性肺炎患儿疗效及血清IL-17和25(OH)D₃水平的影响[J].中国合理用药探索,2021,18(7):49-53.
[5] 杨欣,李勤云.纤维支气管镜肺泡灌洗联合阿奇霉素、甲泼尼龙治疗难治性支原体肺炎患儿的效果[J].河南医学研究,2021,30(7):1231-1233.
[6] 刘会彩,曹珂.付志景,等.肺炎支原体耐药性检测中的CLSI指南应用[J].中华检验医学杂志,2015,38(2):137-138.
[7] 寇志军,马亨曼,全守东,等.谷氨酰胺颗粒联合纤维支气管镜治疗对儿童支原体肺炎支气管黏膜损伤修复和炎症反应水平的影响[J].临床和实验医学杂志,2022,21(4):433-436.
[8] 熊丽君,陈巧彬,林萌.肺部超声对支气管镜下肺泡灌洗术治疗儿童节段性肺炎支原体肺炎的疗效评估[J].福建医药杂志,2021,43(4): 66-69.
[9] 郭丽. 纤维支气管镜下肺泡灌洗治疗小儿肺炎支原体肺炎合并肺不张临床研究[J].中国疗养医学,2020,29(1):74-76.
[10] 韩聪莉,党媛媛,田庆玲,等.纤维支气管镜生理盐水灌注辅助治疗儿童迁延性肺炎支原体肺炎疗效观察[J].中国药师,2020,23(3):488-490.
[11] 曹芳,方识进,华山,等.电子纤维支气管镜保留灌注乙酰半胱氨酸及布地奈德治疗儿童难治性支原体肺炎的临床效果观察[J].中国医药,2020,15(3):369-373.
[12] 何雯,张琪,刘文君,等.大环内酯类抗生素联合纤支镜肺泡灌洗治疗难治性肺炎支原体感染患儿的临床疗效[J].药学服务与研究,2021,21(4):257-261,283.
[13] 吴卫照,刘东成.支气管镜肺泡灌洗治疗幼儿重症肺炎支原体肺炎的疗效观察及肺功能的变化特点[J].实用医学杂志,2019,35(1):132-135.
[14] 朱红国,汪群红,管敏昌,等.经支气管镜肺泡灌洗对难治性肺炎支原体肺炎疗效及血清白细胞介素-6、肿瘤坏死因子-α水平影响[J].中国卫生检验杂志,2021,31(18):2234-2236,2241.
[15] 吴婕妤,郑晶,陈琴.协同式策略式护理在儿童难治性支原体肺炎纤维支气管镜治疗中的应用及依从性分析[J].中外医学研究,2020, 18(33):101-103.
[16] 茹雪,徐颖,刘立飞,等.沙丁胺醇预先吸入给药对肺炎支原体肺炎患儿纤维支气管镜灌洗术中气道不良反应的影响[J].重庆医学, 2020,49(17):2913-2916.
[17] 邸翔,葛宾.治疗时机对RMPP患儿纤维支气管镜支气管肺泡灌洗术治疗效果及预后的影响[J].湖南师范大学学报(医学版),2021, 18(5):44-48.
[18] 杨晓林,寇晓辉,赵丽丽,等.早期支气管镜肺泡灌洗术对难治性支原体肺炎患儿症状改善及近期预后的影响[J].现代诊断与治疗,2020,31(6):967-969.
[19] 成仕,李艺芬,李经猷,等.甲强龙联合纤维支气管镜灌洗对难治性肺炎支原体肺炎患儿免疫水平的影响[J].山西卫生健康职业学院学报,2020,30(3):3-5.
[20] 张阵,彭万胜.纤维支气管镜下支气管肺泡灌洗术在儿童重症肺炎支原体肺炎中的应用价值[J].淮海医药,2021,39(6):616-619.